Eli Lilly is unleashing self-pay discounts across the entirety of its obesity portfolio with new price cuts for higher doses ...

Patients with obesity can now get Zepbound’s strongest doses for a flat rate through Lilly’s self-pay pharmacy. Eli Lilly ...

Eli Lilly has reduced the prices of certain Zepbound vials and introduced higher-dose options, making the weight ... 1 medications remains prohibitively high for many. The move positions Lilly ...

Eli Lilly launches 7.5 mg and 10 mg Zepbound vials for $499, also reducing prices for 2.5 mg and 5 mg vials. Self-pay patients can access Zepbound vials through LillyDirect, bypassing third-party ...

For those who prefer the convenience of getting Zepbound online, several verified options have passed our ... with the pens offering a wider range of doses and the vials requiring syringe ...

Eli Lilly has introduced discounted single-dose vials of tirzepatide (Zepbound) for self-pay patients with obesity to increase accessibility. Eli Lilly responded to the high demand for tirzepatide ...

Eli Lilly officials announced a new program that provides consumers with single-dose vials of the weight-loss drug Zepbound at a discount ... only help us meet the high demand for our obesity ...

GoodRx says that with the support of a healthcare team, a clear transition plan, and a few cost-saving tools, you can make ...

Frustrated Zepbound users have been advocating for vial options for some time ... “patients who are responding well to the high doses want to stay on the high doses,” he said.